Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
31.38
-1.45 (-4.42%)
Jul 10, 2026, 4:00 PM EDT - Market closed
Stoke Therapeutics Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Stoke Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $46. The average 1-year stock price forecast is 46.59% higher than the current stock price, while the lowest is $35 (+11.54%) and the highest is $60 (+91.20%).
Price Target: $46 (+46.59%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Stoke Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 11 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Maintains $40 | Buy | Maintains | $40 | +27.47% | Jul 9, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $39 → $48 | Buy | Maintains | $39 → $48 | +52.96% | Jul 6, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 2, 2026 |
| BTIG | BTIG | Buy Maintains $39 | Buy | Maintains | $39 | +24.28% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $50 | Buy | Maintains | $50 | +59.34% | May 8, 2026 |
Financial Forecast
Revenue This Year
25.96M
from 184.42M
Decreased by -85.92%
Revenue Next Year
45.53M
from 25.96M
Increased by 75.37%
EPS This Year
-3.25
from -0.12
EPS Next Year
-3.08
from -3.25
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 58.7M | ||
| Avg | 26.0M | ||
| Low | 6.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -68.2% | ||
| Avg | -85.9% | ||
| Low | -96.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.07 | ||
| Avg | -3.25 | ||
| Low | -3.49 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |